Can Immunic Inc. (IMUX) stock recover despite sales dropping?
In yesterday’s Wall Street session, Immunic Inc. (NASDAQ:IMUX) shares traded at $2.57, down -10.45% from the previous session. 4 analysts cover Immunic Inc. (NASDAQ:IMUX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $28.00 and a low of […]
